Celldex Therapeutics Inc
(NAS:CLDX)
$
25.43
0.04 (0.16%)
Market Cap: 1.69 Bil
Enterprise Value: 883.77 Mil
PE Ratio: 0
PB Ratio: 2.07
GF Score: 63/100 Celldex Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023 / 05:00PM GMT
Release Date Price:
$26.51
(+2.59%)
Kristen Kluska
Cantor Fitzgerald, L.P. - Analyst
All right. Good afternoon, everybody. Welcome to the afternoon session of the Cantor Healthcare Conference. Really happy to be with the Celldex team. We have Anthony Marucci, CEO; Dr. Diego Alvarado, Executive Director of Research; and Dr. Diane Young, CMO.
Thank you all so much for coming. I really appreciate it.
Diego Alvarado
Celldex Therapeutics, Inc. - Executive Director of Research
Thank you for inviting us. Glad to see you again.
Kristen Kluska
Cantor Fitzgerald, L.P. - Analyst
Yes. So our conference is well timed to this year because you have two data readouts expected before year end. After the success of your healthy volunteer and urticaria studies, we're going to see the first look at barzo, and a new indication, prurigo nodularis.
Questions & Answers
Kristen Kluska
Cantor Fitzgerald, L.P. - Analyst
To set the stage, why you believe this indication is relevant for mast cell targeting?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot